Chemoenzymatic synthesis of heparan sulfate and heparin

References

• Aikawa J-i, Grobe K, Tsujimoto M, Esko JD. 2001. Multiple isozymes of heparan sulfates/heparin GlcNAc N-deacetylase/GlcN N-sulfotransferase: structure and activity of the fourth member, NDST4. J Biol Chem 276:5876–5882.
   Google Scholar
• Arungundram S, Al-Mafraji K, Asong J, Leach III FE, Amster IJ, Venot A, Turnbull JE, Boons GJ. 2009. Modular synthesis of heparan sulfate oligosaccharides for structure–activity relatioship studies. J Am Chem Soc 131:17394–17405.
   PubMed Web of Science ®Google Scholar
• Babu P, Victor XV, Nelsen E, Nguyen TKN, Raman K, Kuberan B. 2011. Hydrogen/deuterium exchange-LC–MS approach to characterize the action of heparan sulfate C5-epimerase. Anal Bioanal Chem 401:237–244.
   Google Scholar
• Balagurunathan K, Beeler DL, Lech M, Wu ZL, Rosenberg RD. 2003a. Chemoenzymatic Synthesis of Classical and Non-classical Anticoagulant Heparan Sulfate Polysaccharides. J Biol Chem 278:52613–52621.
   Google Scholar
• Balagurunathan K, Lech MZ, Beeler DL, Wu ZL, Rosenberg RD. 2003b. Enzymatic synthesis of antithrombin III-binding heparan sulfate pentasaccharide. Nat Biotechnol 21:1343–1346.
   Google Scholar
• Bethea HN, Xu D, Liu J, Pedersen LC. 2008. Redirecting the substrate specificity of heparan sulfate 2-O-sulfotransferase by structurally guided mutagenesis. Proc Natl Acad Sci USA 105:18724–18729.
   Google Scholar
• Bishop J, Schuksz M, Esko JD. 2007. Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 446:1030–1037.
   PubMed Web of Science ®Google Scholar
• Burkart MD, Izumi M, Chapman E, Lin C, Wong C. 2000. Regeneration of PAPS for the enzymatic synthesis of sulfated oligosaccharides. J Org Chem 65:5565–5574.
   Google Scholar
• Chen J, Avci FY, Muñoz EM, McDowell LM, Chen M, Pedersen LC, . 2005. Enzymatically redesigning of biologically active heparan sulfate. J Biol Chem 280:42817–42825.
   PubMed Web of Science ®Google Scholar
• Chen J, Jones CL, Liu J. 2007. Using an enzymatic combinatorial approach to identify anticoagulant heparan sulfate structures. Chem Biol 14:986–993.
   PubMed Web of Science ®Google Scholar
• Chen M, Bridges A, Liu J. 2006. Substrate specificities of recombinant N-acetyl-d-glucosaminyl transferase (KfiA). Biochemistry 45:12358–12365.
   Google Scholar
• Copeland RJ, Balasubramaniam A, Tiwari V, Zhang F, Bridges A, Linhardt RJ, Shukla D, Liu J. 2008. Using a 3-O-sulfated heparin octasaccharide to inhibit the entry of herpes simplex virus 1. Biochemistry 47:5774–5783.
   PubMed Web of Science ®Google Scholar
• de Paz JL, Seeberger PH. 2008. Deciphering the glycosaminoglycan code with the help of microarrays. Mol Biosyst 4:707–711.
   Google Scholar
• Duncan MB, Liu M, Fox C, Liu J. 2006. Characterization of the N-deacetylase domain from the heparan sulfate N-deacetylase/N-sulfotransferase 2. Biochem Biophys Res Commun 339: 1232–1237.
   Google Scholar
• Edavettal SC, Lee KA, Negishi M, Linhardt RJ, Liu J, Pedersen LC. 2004. Crystal structure and mutational analysis of heparan sulfate 3-O-sulfotransferase isoform 1. J Biol Chem 279: 25789–25797.
   PubMed Web of Science ®Google Scholar
• Esko JD, Selleck SB. 2002. Order out of chaos: Assembly of ligand binding sites in heparan sulfate. Ann Rev Biochem 71: 435–471.
   PubMed Web of Science ®Google Scholar
• Hagner-McWhirter A, Hannesson HH, Campbell P, Westley J, Rodén L, Lindahl U, Li JP. 2000. Biosynthesis of heparin/heparan sulfate: kinetic studies of the glucuronyl C5-epimerase with N-sulfated derivatives of the Escherichia coli K5 capsular polysaccharide as substrates. Glycobiology 10:159–171.
   Google Scholar
• Kakuta Y, Sueyoshi T, Negishi M, Pedersen LC. 1999. Crystal structure of the sulfotransferase domain of human heparan sulfate N-deacetylase/N-sulfotransferase 1. J Biol Chem 274: 10673–10676.
   PubMed Web of Science ®Google Scholar
• Kinnunen T, Huang Z, Townsend J, Gatdula MM, Brown JR, Esko JD, Turnbull JE. 2005. Heparan 2-O-sulfotransferase, hst-2, is essential for normal cell migration in Caenorhabditis elegans. Proc Natl Acad Sci USA 102:1507–1512.
   Google Scholar
• Kobayashi M, Habuchi H, Yoneda M, Habuchi O, Kimata K. 1997. Molecular cloning and expression of Chinese hamster ovary cell heparan-sulfate 2-sulfotransferase. J Biol Chem 272:13980–13985.
   Google Scholar
• Li J-P, Gong F, Darwish KE, Jalkanen M, Lindahl U. 2001. Characterization of the D-glucuronyl C5-epimerase involved in the biosynthesis of heparin and heparan sulfate. J Biol Chem 276:20069–20077.
   Google Scholar
• Li J-P, Gong F, Hagner-McWhirter A, Forsberg E, Åbrink M, Kisilevsky R, Zhang X, Lindahl U. 2003. Targeted disruption of a murine glucuronyl C5-epimerase gene results in heparan sulfate lacking L-iduronic acid and in neonatal lethality. J Biol Chem 278:28363–28366.
   PubMedGoogle Scholar
• Li J-p, Hagner-McWhirter A, Kjellen L, Palgi J, Jalkanen M, Lindahl U. 1997. Biosynthesis of Heparin/Heparan Sulfate. cDNA cloning and expression of D-glucuronyl C5-epimerase from bovine lung. J Biol Chem 272:28158–28163.
   PubMed Web of Science ®Google Scholar
• Li K, Bethea HN, Liu J. 2010. Determining the activity of C5-epimerase using an engineered heparan sulfate 2-O-sulfotransferase. J Biol Chem 285:11106–11113.
   Google Scholar
• Lindahl U, Backstrom G, Thunberg L, Leder IG. 1980. Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin. Proc Natl Acad Sci USA 77: 6551–6555.
   PubMed Web of Science ®Google Scholar
• Liu J, Rosenberg RD. 2002. Handbook of glycosyltransferases and their related genes. Tokyo: Springer-Verlag.
   Google Scholar
• Liu R, Liu J. 2011. Enzymatical placement of 6-O-sulfo groups in heparan sulfate. Biochemistry 50:4382–4391.
   Google Scholar
• Liu R, Xu Y, Chen M, Weïwer M, Zhou X, Bridges AS, . 2010. Chemoenzymatic design of heparan sulfate oligosaccharides. J Biol Chem 285:34240–34249.
   PubMed Web of Science ®Google Scholar
• Lundin L, Larsson H, Kreuger J, Kanda S, Lindahl U, Salmivirta M, Claesson-Welsh L. 2000. Selectively desulfated heparin inhibits fibroblast growth factor-induced mitogenicity and angiogenesis. J Biol Chem 275:24653–24660.
   PubMed Web of Science ®Google Scholar
• McDowell LM, Frazier B, Studelska DR, Giljum K, Chen J, Liu J, . 2006. Inhibition or activation of Apert syndrome FGFRs (S252W) signaling by specific glycosaminoglycans. J Biol Chem 281:6924–6930.
   PubMed Web of Science ®Google Scholar
• Moon A, Edavettal SC, Krahn JX, Munoz EM, Negishi M, Linhardt RJ, Liu J, Pedersen LC. 2004. Structural analysis of the sulfotransferase (3-OST-3) involved in the biosynthesis of an entry receptor of herpes simplex virus 1. J Biol Chem 279:45185–45193.
   Google Scholar
• Muñoz E, Xu D, Avci F, Kemp M, Liu J, Linhardt RJ. 2006. Enzymatic synthesis of heparin related polysaccharides on sensor chips: Rapis screening of heparin–protein interactions. Biochem Biophys Res Commun 339:597–602.
   Google Scholar
• Peterson SB, Liu J. 2010. Unraveling the specificity of heparanase utilizing synthetic substrates. J Biol Chem 285:14504–14513.
   PubMed Web of Science ®Google Scholar
• Peterson SP, Frick A, Liu J. 2009. Designing of biologically active heparan sulfate and heparin using an enzyme-based approach. Nat Prod Rep 26:61–627.
   Google Scholar
• Petitou M, van Boeckel CAA. 2004. A synthetic antithrombin III binding pentasaccharide is now a drug! What comes next? Angew Chem Int Ed 43:3118–3133.
   PubMed Web of Science ®Google Scholar
• Renosto F, Seubert PA, Segel IH. 1984. Adenosine 5′-phosphosulfate kinase from Penicillium chrysogenum: purification and kinetic characterization. J Biol Chem 259:2113–2123.
   PubMed Web of Science ®Google Scholar
• Rong J, Habuchi H, Kimata K, Lindahl U, Kusche-Gullberg M. 2001. Substrate specificity of the heparan sulfate hexuronic acid 2-O-sulfotransferase. Biochemistry 40: 5548–5555.
   Google Scholar
• Saribas AS, Mobasseri A, Pristatsky P, Chen X, Barthelson R, Hakes D, Wang J. 2004. Production of N-sulfated polysaccharides using yeast expressed N-deacetylase/N-sulfotransferase-1 (NDST-1). Glycobiology 14:1217–1228.
   Google Scholar
• Sheng Z, Liu R, Xu Y, Liu J. 2011. Determination of the substrate specificity of heparan sulfate N-deacetylase/N-sulfotransferase. J Biol Chem 286:19768–19776.
   Google Scholar
• Shukla D, Liu J, Blaiklock P, Shworak NW, Bai X, Esko JD, . 1999. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 99:13–22.
   PubMed Web of Science ®Google Scholar
• Sismey-Ragatz AE, Green DE, Otto NJ, Rejzek M, Field RA, Deangelis PL. 2007. Chemoenzymatic Synthesis with Distinct Pasteurella Heparosan Synthases. J Biol Chem 282:28321–28327.
   PubMed Web of Science ®Google Scholar
• Smeds E, Habuchi H, Do A-T, Hjertson E, Grundberg H, Kimata K, Lindahl U, Kusche-Gullberg M. 2003. Substrate specificities of mouse heparan sulphate glucosaminyl 6-O-sulfotransferases. Biochem J 372:371–380.
   Google Scholar
• Sugahara K, Kitagawa H. 2000. Recent advances in the study of the biosynthesis and functions of sulfated glycosaminoglycans. Curr Opin Struct Biol 10:518 527.
   Google Scholar
• Wang L, Brown JR, Varki A, Esko JD. 2002. Heparin‘s anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins. J Clin Invest 110:127–136.
   PubMed Web of Science ®Google Scholar
• Wang Z, Xu Y, Yang B, Tiruchinapally G, Sun B, Liu R, . 2010. Preactivation-based one-pot combinatorial synthesis of heparin-like hexasaccharides for the analysis of heparin-protein interactions. Chem Eur J 16:8365–8375.
   Google Scholar
• Wang Z, Yang B, Zhang Z, Ly M, Takieddin M, Mousa SA, . 2011. Control of the heparosan N-deacetylation leads to an improved bioengineered heparin. Appl Biochem Biotech 91:91–99.
   Google Scholar
• Xia G, Chen J, Tiwari V, Ju W, Li J-P, Malmström A, Shukla D, Liu J. 2002. Heparan sulfate 3-O-sulfotransferase isoform 5 generates both an antithrombin-binding site and an entry receptor for herpes simplex virus, type 1. J Biol Chem 277:37912–37919.
   Google Scholar
• Xu D, Moon A, Song D, Pedersen LC, Liu J. 2008. Engineering sulfotransferases to modify heparan sulfate. Nat Chem Biol 4:200–202.
   Google Scholar
• Xu D, Tiwari V, Xia G, Clement C, Shukla D, Liu J. 2005. Characterization of Heparan Sulfate 3-O-Sulfotransferase Isoform 6 and Its Role in Assisting the Entry of Herpes Simplex Virus, Type 1. Biochem J 385:451–459.
   Google Scholar
• Xu Y, Masuko S, Takieddin M, Xu H, Liu R, Jing J, . 2011. Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparins. Science 334:498–501.
   PubMed Web of Science ®Google Scholar
• Zhang Z, McCallum SA, Xie J, Nieto L, Corzana F, Jiménez-Barbero J, . 2008. Solution structure of chemoenzymatically synthesized heparin and its precursors. J Am Chem Soc 130:12998–13007.
   PubMed Web of Science ®Google Scholar
• Zhou X, Chandarajoti K, Pham TQ, Liu R, Liu J. 2011. Expression of heparan sulfate sulfotransferases in Kluyveromyces lactis and preparation of 3′-phosphoadenosine-5′-phosphosulfate. Glycobiology 21:771–780.
   Google Scholar